ESRP2 and nonpapillary renal cell carcinoma: The anti-metastatic impact of Lnc-LSG1 on ccRCC cells was diminished as a consequence of METTL14, which decreased the binding of Lnc-LSG1 to ESRP2 protein via YTHDC1 and enhanced the stability of ESRP2 protein.